Answers are grounded in this paper and cite their sources.
Background/Objectives: Silver nanoparticles (AgNPs) hold considerable promise for antimicrobial, antiviral, and anticancer applications; however, concerns regarding their toxicity remain a major barrier to biomedical use. This study systematically evaluates the acute oral toxicity of five hybrid AgNP–PVP microgel formulations from the Argovit™ family synthesized via electron-beam irradiation. Methods: Previously published acute oral toxicity data for five AgNP formulations were reanalyzed on three compositional dose bases and complemented by an expanded histopathological reevaluation of archived material. Results: All five formulations exhibited high operational cumulative-dose thresholds. On a complete-formulation basis, these ranged from 86,000 to 151,000 mg/kg. Conclusions: A high study-specific operational cumulative-dose threshold was observed across all five formulations rather than being restricted to a single Argovit™ formulation. These findings indicate that high study-specific operational cumulative-dose threshold is not necessarily restricted to biogenically synthesized AgNPs and can also occur in physicochemically synthesized AgNP formulations, supporting further investigation of these hybrid AgNP–PVP microgel formulations for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Maldonado et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: